Back to Agenda
Session 2: It’s all about Timely Access for Patients – How do we ensure they and other experts are heard?
Session Chair(s)
Valentina Strammiello, MA
Director of Programmes
European Patients' Forum, Belgium
Maggie Galbraith
French National Authority for Health (HAS), France
The ultimate aim of the HTA regulation is to contribute to faster patient access. Patient and expert inclusion are prominently reflected in the legislative text, but as procedures are being developed, close engagement between all parties is needed to implement those elements as intended.
Speaker(s)
Setting the Scene: EMA’s Experience with Patient Engagement
Steffen Thirstrup, MD, PhD
European Medicines Agency, Netherlands
Chief Medical Officer
The EUnetHTA Perspective
Maggie Galbraith
French National Authority for Health (HAS), France
Patient’s Perspective
Bettina Ryll
MPNE, Vision Zero Cancer, Sweden
Member of the First EU Cancer Mission Board
Clinical experts’ Perspective
Robin Doeswijk
European Hematology Association, Netherlands
Head of European Affairs
Have an account?